Last reviewed · How we verify
NCT07050875
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting
NA trial testing ABLE Exoskeleton in Acquired Brain Injury (Including Stroke) in 14 participants. Completed in 17 December 2025.
17 December 2025
Quick facts
| Lead sponsor | ABLE Human Motion S.L. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 30 June 2025 |
| Primary completion | 17 December 2025 |
| Estimated completion | 17 December 2025 |
| Sites | 3 locations across Spain |
Drugs / interventions tested
- ABLE Exoskeleton
Conditions studied
- Acquired Brain Injury (Including Stroke) — all drugs for Acquired Brain Injury (Including Stroke) →
Sponsor
ABLE Human Motion S.L.
Who can join
Adults 18 to 80, any sex, with Acquired Brain Injury (Including Stroke). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of the study is to validate the safety and clinical performance of the ABLE Exoskeleton device in people with acquired brain injury during a 10-session gait training program in a clinical setting. The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07050875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ABLE Exoskeleton
Trials testing the same drug.
- NCT07036107 — A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the S · NA · recruiting
- NCT06921551 — Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis · NA · active not recruiting
- NCT06261541 — Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multip · NA · completed
- NCT05643313 — Clinical Investigation on Feasibility and Usability of the ABLE Exoskeleton Device for Individuals With Spinal Cord Inju · NA · completed
- NCT05590065 — Clinical Investigation on the Impact on Safety, Feasibility and Usability of the Design Changes Performed on ABLE Exoske · NA · completed
Other recruiting trials for Acquired Brain Injury (Including Stroke)
Currently open trials in the same condition.
- NCT07303582 — Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities · Phase 4 · recruiting
- NCT07130929 — Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study. · NA · recruiting
- NCT06749197 — Implementation of a Home-based Computerized Cognitive Rehabilitation Program for Patients With ABI · NA · recruiting
- NCT06774287 — Evaluation of the Karman Line Memory Strategy Training · NA · recruiting
Other ABLE Human Motion S.L. trials
Trials by the same sponsor.
- NCT07036107 — A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the S · NA · recruiting
- NCT07062575 — Exoskeleton Training at Home to Assist Participants With Spinal Cord Injuries to Perform Ambulatory Functions. · NA · suspended
- NCT06921551 — Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis · NA · active not recruiting
- NCT06261541 — Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multip · NA · completed
- NCT05643313 — Clinical Investigation on Feasibility and Usability of the ABLE Exoskeleton Device for Individuals With Spinal Cord Inju · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07050875 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ABLE Human Motion S.L.
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07050875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing